561
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Tea Consumption and the Risk of Overall and Grade Specific Prostate Cancer: A Large Prospective Cohort Study of Scottish Men

, , , , &
Pages 790-797 | Received 28 Aug 2011, Accepted 24 Apr 2012, Published online: 14 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kwan-Wai Ng, Zi-Jun Cao, Hu-Biao Chen, Zhong-Zhen Zhao, Lin Zhu & Tao Yi. (2018) Oolong tea: A critical review of processing methods, chemical composition, health effects, and risk. Critical Reviews in Food Science and Nutrition 58:17, pages 2957-2980.
Read now
Yi Yan, Xuemei Sui, Bin Yao, Carl J. Lavie & Steven N. Blair. (2017) Is There a Dose–Response Relationship between Tea Consumption and All-Cause, CVD, and Cancer Mortality?. Journal of the American College of Nutrition 36:4, pages 281-286.
Read now

Articles from other publishers (12)

Robert W. Coppock & Margitta Dziwenka. 2021. Nutraceuticals. Nutraceuticals 697 723 .
Dwayne Tucker, Melisa Anderson, Fabian Miller, Kurt Vaz, Lennox Anderson-Jackson & Donovan McGrowder. 2019. Antioxidants. Antioxidants.
Robert W. Coppock & Margitta Dziwenka. 2016. Nutraceuticals. Nutraceuticals 633 652 .
Quan Zhou, Hui Li, Jian-Guo Zhou, Yuan Ma, Tao Wu & Hu Ma. (2015) Green tea, black tea consumption and risk of endometrial cancer: a systematic review and meta-analysis. Archives of Gynecology and Obstetrics 293:1, pages 143-155.
Crossref
Takuji Suzuki, Noriyuki Miyoshi, Sumio Hayakawa, Shinjiro Imai, Mamoru Isemura & Yoriyuki Nakamura. 2016. Beverage Impacts on Health and Nutrition. Beverage Impacts on Health and Nutrition 49 67 .
Ashley J. R. Carter, Beverly Delarosa & Hannah Hur. (2015) An analysis of discrepancies between United Kingdom cancer research funding and societal burden and a comparison to previous and United States values. Health Research Policy and Systems 13:1.
Crossref
Fen Hu, Fei Wei, Yulei Wang, Bibo Wu, Yuan Fang & Bin Xiong. (2015) EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. Journal of Pharmacological Sciences 128:1, pages 27-34.
Crossref
Susanne M. Henning, Piwen Wang, Jonathan W. Said, Min Huang, Tristan Grogan, David Elashoff, Catherine L. Carpenter, David Heber & William J. Aronson. (2015) Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy. The Prostate 75:5, pages 550-559.
Crossref
Yi-wei Lin, Zheng-hui Hu, Xiao Wang, Qi-qi Mao, Jie Qin, Xiang-yi Zheng & Li-ping Xie. (2014) Tea consumption and prostate cancer: an updated meta-analysis. World Journal of Surgical Oncology 12:1.
Crossref
Feifei Yu, Zhichao Jin, Hong Jiang, Chun Xiang, Jianyuan Tang, Tuo Li & Jia He. (2014) Tea consumption and the risk of five major cancers: a dose–response meta-analysis of prospective studies. BMC Cancer 14:1.
Crossref
M. S. Geybels, B. A. J. Verhage, I. C. W. Arts, F. J. van Schooten, R. A. Goldbohm & P. A. van den Brandt. (2013) Dietary Flavonoid Intake, Black Tea Consumption, and Risk of Overall and Advanced Stage Prostate Cancer. American Journal of Epidemiology 177:12, pages 1388-1398.
Crossref
Milan S. Geybels, Marian L. Neuhouser & Janet L. Stanford. (2013) Associations of tea and coffee consumption with prostate cancer risk. Cancer Causes & Control 24:5, pages 941-948.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.